← Leaderboards
Alexander Matthew Holtz
University Of Michigan At Ann Arbor
$368,605
Attributed
$368,605
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $167.9K · FY2013–25$200K$150K$100K$50K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$368,605 · 2
By mechanism
K08$335,880 · 1
F31$32,725 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Vibha N Lama$11,271,662
- Orly Reiner$185,681
- Caitlin Anne Orsini$2,709,027
Others in their field
Top investigators on “Pathology”
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Paul S. Aisen · Cognition Therapeutics, Inc.$155,099,919
- Reisa A. Sperling · Banner Health$154,825,070
- Ronald T Mitsuyasu · University Of California Los Angeles$145,092,412
- Joseph E Robertson · Oregon Health & Science University$126,125,279
Research focus
PathologyDefectSignal TransductionPatternEmbryoMediatingMutationReceptorCellsAwardBlood VesselsAutologousBmpr2 GeneBostonActivities Of Daily LivingDirected DifferentiationCellular BiologyCell ProliferationCell PhysiologyAlveolar Capillary Dysplasia With Misalignment Of Pulmonary VeinsCell Replacement TherapyCollaborationsCell Differentiation ProcessCareer Development
Grant awards (3)
Endothelial cell-based therapy for pulmonary vascular disease using induced pluripotent stem cells$167,940
K08 · FY2025 · HL · contact PI
Endothelial cell-based therapy for pulmonary vascular disease using induced pluripotent stem cells$167,940
K08 · FY2024 · HL · contact PI
PTCH2-Mediated Antagonism of Hedgehog Signaling During Vertebrate Neural Patterni$32,725
F31 · FY2013 · NS · contact PI